{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:06:02Z","timestamp":1761717962863,"version":"3.44.0"},"reference-count":6,"publisher":"BMJ","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Fam Plann Reprod Health Care"],"accepted":{"date-parts":[[2001,3,30]]},"published-print":{"date-parts":[[2001,7]]},"abstract":"\n Objective<\/jats:title>\n To assess the first year's use with the GyneFix intra-uterine device. This has been used in Liverpool since early 1997. It is offered mainly to nulliparous women wishing to use an effective non-hormonal method and parous women who have had pain with, or expulsion of, a framed device previously. It is also used as emergency contraception.<\/jats:p>\n <\/jats:sec>\n \n Design<\/jats:title>\n Retrospective study, by means of casenote review and client questionnaire.<\/jats:p>\n <\/jats:sec>\n \n Participants<\/jats:title>\n All GyneFix users from February 1997 to January 1998; 215 women in total.<\/jats:p>\n <\/jats:sec>\n \n Main outcome measures<\/jats:title>\n Data were extracted from casenotes to determine reasons for choice of GyneFix, parity, whether the insertion was planned or as an emergency measure, problems reported at follow-up and reasons for removal. Users were asked by questionnaire to comment on insertion procedure, menstrual or other changes since insertion and to state their overall satisfaction.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Over half of the users (57%) were nulliparous and a quarter of insertions were for emergency contraceptive use. A third reported that insertion was 'very painful'. Half reported that their periods had become heavier since insertion, but only 8% said that they were now unmanageable. Unacceptable bleeding was the most common reason for removal. Some reported intermenstrual bleeding and dysmenorrhoea. Satisfaction with the GyneFix was high; 86% of questionnaire responders said that they would recommend it to a friend.<\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n The GyneFix is well accepted in Liverpool in appropriately selected clients, and is an effective nonhormonal method for nulliparous as well as parous women.<\/jats:p>\n <\/jats:sec>","DOI":"10.1783\/147118901101195542","type":"journal-article","created":{"date-parts":[[2005,3,5]],"date-time":"2005-03-05T01:30:57Z","timestamp":1109986257000},"page":"139-144","source":"Crossref","is-referenced-by-count":10,"title":["Introduction of the GyneFix intra-uterine device into the UK: Client satisfaction survey and casenotes review"],"prefix":"10.1136","volume":"27","author":[{"given":"Joanne","family":"Dennis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Webb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meera","family":"Kishen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2001,7,1]]},"reference":[{"issue":"2","key":"ref_1","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/BF01987278","article-title":"The frameless GyneFix\u00ae intrauterine implant: a major improvement in efficacy, expulsion and tolerance","volume":"11","author":"H, Van Kets; M, Vrijens; Y, Van Trappen","year":"1995","unstructured":"Van Kets H, Vrijens M, Van Trappen Y, et al. The frameless GyneFix\u00ae intrauterine implant: a major improvement in efficacy, expulsion and tolerance. Advances in Contraception 1995; 11(2): 131\u2013142.","journal-title":"Advances in Contraception"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0010-7824(95)00140-9","article-title":"UNFPA and WHO Special Programme of Research, Development and Research Training in Human Reproduction, World Bank: IUD Research Group. The TCu 380A and the Frameless IUD \u201cthe FlexiGard\u201d: Interim three-year data from an international multicenter trial","volume":"52","author":"U.N.D.P.","year":"1995","unstructured":"UNDP, UNFPA and WHO Special Programme of Research, Development and Research Training in Human Reproduction, World Bank: IUD Research Group. The TCu 380A and the Frameless IUD \u201cthe FlexiGard\u201d: Interim three-year data from an international multicenter trial. Contraception 1995; 52: 77\u201383.","journal-title":"Contraception"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0010-7824(96)00036-4","article-title":"Performance of the TCu 380A and Cu-Fix IUDs in an international randomized trial","volume":"53","author":"Rosenberg, M.; Foldesy, R.; Mishell, D.","year":"1996","unstructured":"Rosenberg M, Foldesy R, Mishell D, et al. Performance of the TCu 380A and Cu-Fix IUDs in an international randomized trial. Contraception 1996; 53: 197\u2013203.","journal-title":"Contraception"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0010-7824(00)00087-1","article-title":"Performance of the frameless GyneFix and the TCu 380A IUDs in a three-year multicenter randomized comparative trial in parous women","volume":"61","author":"Wu, S.; J, Hu; Wildemeersch, D.","year":"2000","unstructured":"Wu S, Hu J and Wildemeersch D. Performance of the frameless GyneFix and the TCu 380A IUDs in a three-year multicenter randomized comparative trial in parous women. Contraception 2000. 61: 91\u201398.","journal-title":"Contraception"},{"key":"ref_5","article-title":"Summary and conclusions of the CMO\u2019s Expert Advisory Group on Chlamydia Trachomatis","author":"on Chlamydia Trachomatis, Chief Medical Officer\u2019s Expert Advisory Group","year":"1998","unstructured":"Chief Medical Officer\u2019s Expert Advisory Group on Chlamydia Trachomatis. Summary and conclusions of the CMO\u2019s Expert Advisory Group on Chlamydia Trachomatis. Department of Health, 1998."},{"key":"ref_6","article-title":"Screening, treating and contact tracing for asymptomatic Chlamydia infection in a young people\u2019s clinic (in Bootle) by Outreach Health Advisor is both acceptable and successful","author":"Jones, K.; Darcy, A.; Webb, A.","year":"2000","unstructured":"Jones K, Darcy A, Webb A, et al. Screening, treating and contact tracing for asymptomatic Chlamydia infection in a young people\u2019s clinic (in Bootle) by Outreach Health Advisor is both acceptable and successful. European Journal of Contraception and Reproductive Health Care 2000; 5 (1): 53(a).","journal-title":"European Journal of Contraception and Reproductive Health Care"}],"container-title":["Journal of Family Planning and Reproductive Health Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1783\/147118901101195542","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T19:25:48Z","timestamp":1757100348000},"score":1,"resource":{"primary":{"URL":"https:\/\/jfprhc.bmj.com\/lookup\/doi\/10.1783\/147118901101195542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,7]]},"references-count":6,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2001,7,1]]},"published-print":{"date-parts":[[2001,7]]}},"alternative-id":["10.1783\/147118901101195542"],"URL":"https:\/\/doi.org\/10.1783\/147118901101195542","relation":{},"ISSN":["1471-1893","2045-2098"],"issn-type":[{"type":"print","value":"1471-1893"},{"type":"electronic","value":"2045-2098"}],"subject":[],"published":{"date-parts":[[2001,7]]}}}